Heroic Empire Acquisition, a Hong Kong-based special purpose acquisition company (SPAC), has filed with the US Securities and Exchange Commission (SEC) to raise up to $100 million through an initial public offering (IPO). The company plans to target businesses in artificial intelligence, biotechnology, technology, media and telecommunications (TMT), new energy, and advanced manufacturing across Asia and North America.

Company Background

Founded in 2021, Heroic Empire Acquisition is led by CEO and Chairman William Ip, Managing Director of Amasse Capital, and CFO and Director Mitchell Cariaga, President of Orange Grove Trading and General Partner of Citrus Grove Capital.

The SPAC intends to identify and complete a business combination with a company operating in one of its targeted sectors. Its geographic focus spans Asia and North America, although the filing information does not identify a specific acquisition candidate.

Heroic Empire Acquisition previously pursued a Nasdaq IPO in February 2022, seeking to raise $75 million. The company withdrew that filing in December 2023 before submitting its latest proposal.

IPO Details

Heroic Empire Acquisition plans to raise $100 million by offering 10 million units at $10 each. Every unit consists of one share of common stock and one right to receive one-fourth of one ordinary share upon completion of an initial business combination.

The company filed confidentially on January 21, 2026, and subsequently filed publicly with the SEC on Tuesday. It intends to list on the Nasdaq under the proposed ticker symbol HEACU.RC.

A.G.P. and Haitong International are serving as joint bookrunners for the offering.

Target Sectors and Acquisition Strategy

Heroic Empire Acquisition plans to pursue opportunities across artificial intelligence, biotechnology, TMT, new energy, and advanced manufacturing. These sectors represent a broad range of technology-driven and industrial businesses that could become potential acquisition candidates.

Its cross-regional mandate covers Asia and North America. However, the available information does not specify acquisition criteria beyond the targeted sectors and geographies, nor does it disclose a potential transaction, target valuation, or expected timetable for completing a business combination.

Market Context and Considerations

The proposed $100 million offering would provide Heroic Empire Acquisition with capital to pursue a future business combination. Its renewed IPO effort follows the withdrawal of its earlier $75 million proposal, marking another attempt to enter the public markets.

The unit structure also provides investors with a right to receive an additional fraction of a share if a business combination is completed. The final investment considerations will depend on the offering terms, the SPAC’s eventual acquisition target, and the conditions of any proposed transaction.

Risks and Challenges

Heroic Empire Acquisition has not disclosed a specific acquisition target, leaving the nature and timing of a potential business combination uncertain. Its broad sector mandate also means that investors do not yet have a defined operating business or financial performance to evaluate.

The company’s earlier withdrawn IPO is part of its filing history, but the available information does not explain why that offering was withdrawn or establish the reasons behind the current proposal. Any future transaction will depend on identifying a suitable target and completing the business-combination process.

Closing Insights

Heroic Empire Acquisition’s proposed $100 million IPO would support a SPAC focused on technology, biotechnology, energy, and advanced manufacturing opportunities across Asia and North America. The offering follows an earlier withdrawn IPO attempt and introduces a unit structure combining common stock with a right tied to a future business combination. Its longer-term investment profile will depend on the completion of the offering and the quality, valuation, and terms of any eventual acquisition.